Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Completed · Phase 1

Conditions studied: Prostate Cancer

In brief

Phase I trial to study the effectiveness of vaccine therapy in treating patients with metastatic prostate cancer. Vaccines may make the body build an immune response to kill tumor cells.

Key facts

Study ID

NCT00004029

Run by

National Cancer Institute (NCI)

People needed

46

Starts

1996-12-01

Last updated by the study team

2013-02-11

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
• Brigham and Women's Hospital — Boston, Massachusetts, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.